News in Depth
The potential for faster innovation, and the power of collaboration and workplace and operations modernization are emerging into high relief as...
Pandemic Experience Showcases the Potential for Faster Innovation, More Collaboration, and Workplace and Operations Modernization
The potential for faster innovation, and the power of collaboration and workplace and operations modernization are emerging into high relief as...
Biomanufacturer Raw Material Control on Regulatory Front Burner as Analytical Power and Formulation Challenges Intensify
A more powerful analytical toolbox is allowing industry and regulators to better understand how biotech product manufacturers can improve the...
Welcome to International Pharmaceutical Quality (IPQ)
INTERNATIONAL PHARMACEUTICAL QUALITY provides in-depth coverage of emerging drug, biologic and combination product CMC and GMP issues and...
CBER Advice on CGT Process and Facility Management Includes Early Consideration of Engineering and Capacity Needs
As its experience grows with reviewing cell and gene therapy (CGT) processes, equipment and facilities, CBER is strongly recommending that firms...
CBER Reviewers Are Working With Sponsors in Exploring CMC Flexibility for Cell and Gene Therapies
Reviewers with FDA’s Center for Biologics Evaluation and Research (CBER) are working with sponsors on determining how and where flexibility can...
The Role of Quality Culture in Data Integrity Is Getting More Attention As Regulator and Industry DI Guidances Evolve
The importance of quality culture is finding more clear expression in the refinement of regulator and industry guidances that have been...
FDA's Focus Has Sharpened on Water Systems in the Wake of Nonsterile Product Microbial Contamination
FDA has been sharpening its focus on water systems during inspections of nonsterile liquid products as microbial contamination problems of...



